Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Sales (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Return on Sales data on record, last reported at 2.33% in Q4 2025.

  • For Q4 2025, Return on Sales fell 240.0% year-over-year to 2.33%; the TTM value through Dec 2025 reached 0.3%, up 17.0%, while the annual FY2025 figure was 1.32%, 147.0% down from the prior year.
  • Return on Sales reached 2.33% in Q4 2025 per COLL's latest filing, down from 1.45% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.88% in Q2 2021 and bottomed at 2.33% in Q4 2025.
  • Average Return on Sales over 5 years is 0.14%, with a median of 0.06% recorded in 2024.
  • Peak YoY movement for Return on Sales: soared 86bps in 2022, then tumbled -240bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.91% in 2021, then soared by 94bps to 0.06% in 2022, then surged by 662bps to 0.31% in 2023, then crashed by -78bps to 0.07% in 2024, then crashed by -3488bps to 2.33% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 2.33% in Q4 2025, 1.45% in Q3 2025, and 0.09% in Q2 2025.